Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 6
2006 7
2007 8
2008 8
2009 5
2010 6
2011 2
2012 3
2013 7
2014 11
2015 14
2016 7
2017 17
2018 10
2019 5
2020 12
2021 15
2022 6
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib.
Malapelle U, Ricciuti B, Baglivo S, Pepe F, Pisapia P, Anastasi P, Tazza M, Sidoni A, Liberati AM, Bellezza G, Chiari R, Metro G. Malapelle U, et al. Among authors: sidoni a. Recent Results Cancer Res. 2018;211:257-276. doi: 10.1007/978-3-319-91442-8_18. Recent Results Cancer Res. 2018. PMID: 30069773 Review.
Biobanking-related bioethical and legal unresolved issues.
Cippitani R, Mandarano M, Pelliccia C, Colcelli V, Sidoni A. Cippitani R, et al. Among authors: sidoni a. Virchows Arch. 2022 Nov 16. doi: 10.1007/s00428-022-03450-0. Online ahead of print. Virchows Arch. 2022. PMID: 36383246 No abstract available.
The Effect of Cholesterol in MCF7 Human Breast Cancer Cells.
Albi E, Mandarano M, Cataldi S, Ceccarini MR, Fiorani F, Beccari T, Sidoni A, Codini M. Albi E, et al. Among authors: sidoni a. Int J Mol Sci. 2023 Mar 21;24(6):5935. doi: 10.3390/ijms24065935. Int J Mol Sci. 2023. PMID: 36983016 Free PMC article.
Current Challenges for IDO2 as Target in Cancer Immunotherapy.
Mondanelli G, Mandarano M, Belladonna ML, Suvieri C, Pelliccia C, Bellezza G, Sidoni A, Carvalho A, Grohmann U, Volpi C. Mondanelli G, et al. Among authors: sidoni a. Front Immunol. 2021 Apr 21;12:679953. doi: 10.3389/fimmu.2021.679953. eCollection 2021. Front Immunol. 2021. PMID: 33968089 Free PMC article. Review.
Polyangiitis overlap syndrome: a rare clinical entity.
Bruno L, Mandarano M, Bellezza G, Sidoni A, Gerli R, Bartoloni E, Perricone C. Bruno L, et al. Among authors: sidoni a. Rheumatol Int. 2023 Mar;43(3):537-543. doi: 10.1007/s00296-023-05281-x. Epub 2023 Jan 31. Rheumatol Int. 2023. PMID: 36719484 Free PMC article. Review.
Future options for ALK-positive non-small cell lung cancer.
Iacono D, Chiari R, Metro G, Bennati C, Bellezza G, Cenci M, Ricciuti B, Sidoni A, Baglivo S, Minotti V, Crinò L. Iacono D, et al. Among authors: sidoni a. Lung Cancer. 2015 Mar;87(3):211-9. doi: 10.1016/j.lungcan.2014.12.017. Epub 2015 Jan 3. Lung Cancer. 2015. PMID: 25601484 Review.
148 results